Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ARWR — Arrowhead Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

FEB 5, 2026
REVENUE
$264.0M +2.9%
NET MARGIN
11.7% +20.9 PTS
EPS
$0.22 +229.4%
FREE CASH FLOW
$11.3M -12.8%

No summary has been written for this call yet.